Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market
· media contact
AI Briefing
- • Evidation's survey of 165,000 people shows continued growth potential in the GLP-1 market.
- • The market is growing unevenly, with disparities across demographics such as age, gender, and income.
- • Access, affordability, awareness, and treatment pathways may shape market outcomes.
Source Summary
SAN MATEO, Calif.--(BUSINESS WIRE)--Evidation, the leader in direct-from-participant real-world data and health research, today announced new insights from multiple, longitudinal surveys showing that the market for GLP-1s and prescription weight management is growing rapidly, but unevenly, across demographic subpopulations including age, gender, and income. The insights point to a highly segmented market, where access, affordability, awareness, and treatment pathways may shape who starts treatm
Advertisement